ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,274.75
0.20%
Dow Jones
44,722.06
-0.31%
Gold vs US Dollar
2,626.97
-0.38%
Brent Oil
72.28
-0.16%
Bitcoin
96,425.89
0.47%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sonnet BioTherapeutics Holdings Inc (SONN)

  7. Sonnet BioTherapeutics Holdings Inc (SONN) News

Sonnet BioTherapeutics (SONN)

Sonnet BioTherapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SONN
DateTimeSourceHeadlineSymbolCompany
26/11/202422:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
12/11/202414:15GlobeNewswire Inc.Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” SegmentNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
08/11/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/11/202414:22Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
07/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
06/11/202418:20GlobeNewswire Inc.Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
06/11/202414:22Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
06/11/202413:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
06/11/202413:30GlobeNewswire Inc.Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug CandidatesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
04/11/202414:01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
28/10/202413:01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/10/202412:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/10/202412:45GlobeNewswire Inc.Sonnet BioTherapeutics Inc. Regains Compliance with NasdaqNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/10/202412:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/10/202412:45GlobeNewswire Inc.Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in IndiaNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
04/10/202412:30GlobeNewswire Inc.Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive ProgramsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/09/202413:00GlobeNewswire Inc.Sonnet BioTherapeutics Announces Launch of CEO Corner PlatformNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/09/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
25/09/202412:30GlobeNewswire Inc.Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock SplitNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
18/09/202412:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
18/09/202412:30GlobeNewswire Inc.Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid TumorsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
12/09/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/09/202420:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
04/09/202413:15GlobeNewswire Inc.Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell SeriesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/08/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/08/202421:28Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/08/202421:27Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/08/202412:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/08/202412:45GlobeNewswire Inc.Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic CancerNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
14/08/202412:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:SONN

Your Recent History

LSE
BOO
Boohoo
LSE
VAST
Vast Resources
LSE
GRL
Goldstone Resources
LSE
AAL
Anglo American
LSE
BVC
Batm Advanced Communicat...
LSE
TERN
Tern
LSE
SRB
Serabi Gold
LSE
ORCP
Oracle Power
LSE
NFDS
Northern Foods
LSE
RRR
Red Rock Resources
LSE
LPA
Lpa
LSE
TW.
Taylor Wimpey
LSE
TEK
Tekcapital
LSE
SIG
Signature Aviation
LSE
GWMO
Great Western Mining
LSE
KMR
Kenmare Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Gold Trader

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £3655.44 only £1462.17